Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Cardiology

A Family Journey: Screening & Genetic Counseling in FIDC

At a Glance

Familial isolated dilated cardiomyopathy (FIDC) is an inherited condition that requires proactive cascade screening. First-degree relatives should undergo clinical heart tests and genetic screening. A genetic counselor can help families navigate communication, emotional impacts, and testing.

Because Familial Isolated Dilated Cardiomyopathy (FIDC) is an inherited condition, your diagnosis is a vital piece of information for your entire family [1][2]. While the idea of a “family heart condition” can be overwhelming, the purpose of screening is not just to find disease, but to provide peace of mind and early protection for those you love [3][4].

Cascade Screening: A Step-by-Step Approach

The most effective way to protect your family is through a process called Cascade Screening [1]. This starts with you (the “proband”) and then moves outward to your first-degree relatives—your parents, siblings, and children [5][1].

There are two distinct types of screening used in this process:

  • Genetic Screening: A simple blood or saliva test used to look for the specific mutation (misspelling) found in your DNA [6][7]. Crucial Caveat: A relative can only be “cleared” by genetic testing if the exact genetic mutation causing the disease has already been identified in you. If they test negative for that specific gene, they may be cleared from needing frequent heart check-ups [2][3]. If your genetic test is inconclusive, your relatives must undergo lifelong clinical screening.
  • Clinical Screening: This involves physical tests like an ECG (to check heart rhythm) and an Echocardiogram (to check heart structure and strength) [1][8]. These tests look for the physical signs of the disease, regardless of what the genes say [9].

Screening Frequency for Asymptomatic Relatives

Even if your family members feel completely healthy, regular monitoring is crucial because FIDC often shows age-dependent penetrance—meaning the condition might not appear until later in life [8][10].

Group Recommended Screening Frequency
Children Baseline check typically starts around age 10-12, though earlier screening may be done if there is a history of early-onset disease in the family [11][12].
Adolescents & Young Adults Every 1–3 years, depending on the specific genetic risk and initial test results [8][10].
Adults Generally every 3–5 years if initial tests are normal, or more frequently if a high-risk gene (like LMNA) is present [3][8].

The Role of Genetic Counseling

A Genetic Counselor is a specialized healthcare professional who helps families navigate the emotional and practical side of inherited disease [13][14]. They provide a safe space to discuss:

  • Managing Guilt: It is common for parents to feel responsible for “passing on” a gene [13]. A counselor can help you process these emotions and understand that we cannot control which genes we pass to our children.
  • Communication: They can help you find the right words to talk to your siblings or children about their risk, often providing a “family letter” to simplify the conversation [15].
  • Practical Concerns: Counselors can guide you through the implications of genetic testing for life insurance or future family planning [13].

Knowing your family’s genetic status is an act of empowerment. It allows at-risk relatives to be monitored closely, ensuring that if the heart ever starts to weaken, they can begin the “Four Pillars” of treatment years before symptoms would have otherwise appeared [4][5].

To understand how you will be monitored over time, review The Long View: Survivorship & Monitoring with FIDC.

Common questions in this guide

Who in my family needs to be screened for FIDC?
Cascade screening is the most effective way to protect your family. It starts with testing first-degree relatives, which includes your parents, siblings, and children.
What is the difference between genetic and clinical screening for heart conditions?
Genetic screening looks for the specific DNA mutation causing the disease using a blood or saliva test. Clinical screening uses physical tests, like an ECG and echocardiogram, to check the heart's actual rhythm, structure, and strength.
If a relative tests negative for the family's genetic mutation, do they still need regular heart check-ups?
If your exact genetic mutation is known and a relative tests negative for it, they may be cleared from needing frequent clinical check-ups. However, if your own genetic test was inconclusive, your relatives must undergo lifelong clinical screening to monitor their heart health.
How often should healthy family members be screened for FIDC?
Screening frequency depends on age and genetic risk. Children typically have a baseline check around age 10 to 12. Adolescents and young adults are usually screened every 1 to 3 years, while adults are checked every 3 to 5 years if their initial tests are normal.
How can a genetic counselor help my family?
A genetic counselor helps you navigate the emotional and practical sides of an inherited disease. They can help process feelings of guilt, provide letters to help explain the diagnosis to relatives, and guide you through life insurance and family planning concerns.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you provide me with a 'family letter' to help me explain the diagnosis and screening needs to my relatives?
  2. 2.Based on the gene identified in my case, at what age should my children have their first baseline Echo and ECG?
  3. 3.If a relative tests negative for the family's genetic mutation, do they still need regular heart check-ups?
  4. 4.How often should my asymptomatic, genotype-positive relatives be screened—every year, or every 3 years?
  5. 5.Is there a specialized cardio-genetics clinic or a counselor you recommend for my family?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Familial dilated cardiomyopathy: A multidisciplinary entity, from basic screening to novel circulating biomarkers.

    de Gonzalo-Calvo D, Quezada M, Campuzano O, et al.

    International journal of cardiology 2017; (228()):870-880 doi:10.1016/j.ijcard.2016.11.045.

    PMID: 27889554
  2. 2

    The role of genetic testing in management and prognosis of individuals with inherited cardiomyopathies.

    Hespe S, Gray B, Puranik R, et al.

    Trends in cardiovascular medicine 2025; (35(1)):34-44 doi:10.1016/j.tcm.2024.06.002.

    PMID: 39004295
  3. 3

    Family Screening in Dilated Cardiomyopathy: Prevalence, Incidence, and Potential for Limiting Follow-Up.

    Vissing CR, Espersen K, Mills HL, et al.

    JACC. Heart failure 2022; (10(11)):792-803 doi:10.1016/j.jchf.2022.07.009.

    PMID: 36328645
  4. 4

    Arrhythmic Genotypes in Familial Dilated Cardiomyopathy: Implications for Genetic Testing and Clinical Management.

    Peters S, Kumar S, Elliott P, et al.

    Heart, lung & circulation 2019; (28(1)):31-38 doi:10.1016/j.hlc.2018.09.010.

    PMID: 30482687
  5. 5

    Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.

    Pinto YM, Elliott PM, Arbustini E, et al.

    European heart journal 2016; (37(23)):1850-8 doi:10.1093/eurheartj/ehv727.

    PMID: 26792875
  6. 6

    The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy.

    Morales A, Hershberger RE

    The Canadian journal of cardiology 2015; (31(11)):1309-12.

    PMID: 26518443
  7. 7

    Genetic analysis using targeted next-generation sequencing of sporadic Chinese patients with idiopathic dilated cardiomyopathy.

    Li M, Xia S, Xu L, et al.

    Journal of translational medicine 2021; (19(1)):189 doi:10.1186/s12967-021-02832-3.

    PMID: 33941202
  8. 8

    Role of family history and clinical screening in the identification of families with idiopathic dilated cardiomyopathy in Johannesburg, South Africa.

    Bailly C, Henriques S, Tsabedze N, Krause A

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2019; (109(9)):673-678 doi:10.7196/SAMJ.2019.v109i9.13936.

    PMID: 31635593
  9. 9

    Diverse Concepts in Definitions of Dilated Cardiomyopathy: Theory and Practice.

    Myers MC, Breznen B, Zhong Y, et al.

    Cardiology research 2024; (15(5)):319-329 doi:10.14740/cr1679.

    PMID: 39420975
  10. 10

    Genetic Screening Reveals Heterogeneous Clinical Phenotypes in Patients with Dilated Cardiomyopathy and Troponin T2 Variants.

    Weis A, Krueck S, Dombrowsky G, et al.

    Journal of personalized medicine 2023; (13(4)) doi:10.3390/jpm13040611.

    PMID: 37108997
  11. 11

    Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study.

    Jansen M, de Brouwer R, Hassanzada F, et al.

    JACC. Heart failure 2024; (12(1)):134-147 doi:10.1016/j.jchf.2023.07.007.

    PMID: 37565978
  12. 12

    Next-Generation Sequencing Reveals Novel Genetic Variants for Dilated Cardiomyopathy in Pediatric Chinese Patients.

    Wang Y, Han B, Fan Y, et al.

    Pediatric cardiology 2022; (43(1)):110-120 doi:10.1007/s00246-021-02698-8.

    PMID: 34350506
  13. 13

    The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy-A systematic review and meta-analysis.

    Cirino AL, Harris SL, Murad AM, et al.

    Journal of genetic counseling 2022; (31(6)):1290-1305 doi:10.1002/jgc4.1604.

    PMID: 35799446
  14. 14

    What kind of information is requested by patients and families with genetic disorders? : The analysis of an online patient community in South Korea.

    Lee SA, Park S, So MK, et al.

    Journal of community genetics 2025; (16(6)):787-797 doi:10.1007/s12687-025-00827-x.

    PMID: 40844583
  15. 15

    Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.

    Bednar EM, Rauh-Hain JA, Garcia JJ, et al.

    Cancer prevention research (Philadelphia, Pa.) 2024; (17(1)):19-28 doi:10.1158/1940-6207.CAPR-23-0303.

    PMID: 37913800

This page provides educational information about genetic screening for familial isolated dilated cardiomyopathy (FIDC). Always consult a genetic counselor or cardiologist for personalized medical advice regarding your family's specific genetic risk.

Get notified when new evidence is published on Familial isolated dilated cardiomyopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.